Spontaneous splenic infarction associated with sumatriptan use.
 |
Related Articles |
Spontaneous splenic infarction associated with sumatriptan use.
J Headache Pain. 2006 Jun 15;
Authors: Arora A, Arora S
Triptans are specific agonists of the serotonergic 5-HT(1B/1D) receptors that have increasingly been used in the treatment of migraine and cluster headaches. Though they are generally considered safe, there have been a few reports of myocardial infarction and stroke associated with triptan use. We report a patient who developed spontaneous splenic infarction after the use of sumatriptan for the treatment of migraine headache.
PMID: 16767537 [PubMed - as supplied by publisher]
Related posts:
- Rupture of splenic artery aneurysm with portal hypertension during pregnancy: a case report.
- Comorbid neuropathologies in migraine.
- Genetic Variants of Arachidonate 5-Lipoxygenase-Activating Protein, and Risk of Incident Myocardial Infarction and Ischemic Stroke. A Nested Case-Control Approach.
- Gelstat Migraine (sublingually administered feverfew and ginger compound) for acute treatment of migraine when administered during the mild pain phase.
- Insights into the pathophysiology of ST-elevation myocardial infarction.